Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Commentary

Minding (and Reducing) the Detection Gap: An Algorithm to Diagnose TB With HIV Infection

Silvia S. Chiang and Andrea T. Cruz
Pediatrics September 2019, 144 (3) e20191797; DOI: https://doi.org/10.1542/peds.2019-1797
Silvia S. Chiang
aDepartment of Pediatrics, Alpert School of Medicine, Brown University, Providence, Rhode Island;
bCenter for International Health Research, Rhode Island Hospital, Providence, Rhode Island; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea T. Cruz
cDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF
  • Abbreviation:
    IGRA —
    interferon γ release assay
  • Globally, an estimated 239 000 children younger than 15 years, including 39 000 with HIV infection, die of tuberculosis each year. More than 95% of these deaths occur in children who did not receive tuberculosis treatment.1 Children treated for tuberculosis have low mortality rates.2 Therefore, it is likely that the number of childhood tuberculosis deaths would decline dramatically if the case-detection ratio were improved from its current proportion of ∼1 in 3. Multiple factors contribute to this dismal case-detection rate, including the health care barriers faced by the poor and marginalized populations most affected by tuberculosis, the inability of most children to expectorate sputum for sample collection, and the paucibacillary nature of childhood tuberculosis, which leads to infrequent microbiologic confirmation. The most sensitive microbiologic test (culture) identifies Mycobacterium tuberculosis in just 25% of cases.3

    Health officials in countries with high tuberculosis burden have prioritized contagious adult cases as the drivers of the tuberculosis epidemic. Consequently, front-line providers often lack adequate training to evaluate children for tuberculosis.4 Because their clinical training emphasizes tuberculosis in adults, which has a much higher rate of microbiologic confirmation, providers may be reluctant to start antituberculosis therapy without identification of M tuberculosis or may have false confidence in negative testing results. This confluence of factors results in children with tuberculosis experiencing diagnostic delays or never receiving a diagnosis at all. Children who do not receive a diagnosis are not reported as having tuberculosis, resulting in a vicious cycle of childhood cases not being counted and thus not being a perceived public health problem.

    Diagnostic challenges as well as the consequences of missing a tuberculosis diagnosis are exacerbated in the estimated 1.8 million children living with HIV around the world.5 Children with HIV have a risk of progression from tuberculosis infection to disease that is estimated to be at least 8 times higher than that for children without HIV.6 Children with HIV infection are also 8 to 14 times more likely to die of tuberculosis disease compared with children without HIV.2

    Previous clinical-decision scores developed for diagnosing childhood pulmonary tuberculosis have suboptimal sensitivity and specificity in children with HIV,7 in part because of atypical symptomatology and radiographic findings and because of overlapping findings with other opportunistic infections. In this issue of Pediatrics, Marcy et al8 describe the development and internal validation of a treatment-decision score for pulmonary tuberculosis in children <14 years old infected with HIV in 4 countries in sub-Saharan Africa and Southeast Asia. This score integrated symptoms, chest radiography, abdominal ultrasonography, and Xpert MTB/RIF (a real-time molecular assay widely available in high-burden countries). The authors also assessed the added value of tuberculin skin tests and interferon-γ release assays (IGRAs). The authors evaluated the sensitivity and specificity of several models, including those integrating all components of the tool, as well as models that did not include IGRAs and abdominal ultrasonography, which may not be available in all settings. The sensitivity and specificity of the optimal tool (which did not incorporate IGRAs) were 89% and 61%, respectively. Importantly, the tool can be scaled to the available resources of different settings.

    Considering the limitations of the current diagnostic armamentarium for childhood tuberculosis, particularly in the context of HIV co-infection, these results are promising. The authors’ findings require validation in other settings because the inclusion and exclusion criteria and the study clinicians’ high index of suspicion for tuberculosis may have impacted the performance of the diagnostic tool. Additionally, almost 40% of the subjects in this trial had mild to nonsignificant immunosuppression, and the model may perform differently in settings where children have less well-controlled HIV infection. Moreover, pediatric radiographic quality and interpretation skills vary widely between settings, and studies have revealed poor interrater agreement on the presence of hilar lymphadenopathy.9 Finally, the impact of this clinical-decision score should be evaluated with respect to key clinical outcomes, including the case-detection ratio of childhood tuberculosis, time to treatment initiation, and treatment outcomes.

    Compared with microbiologic assays, this decision tool may improve diagnostic sensitivity by >60%. Given the high mortality risk associated with missing tuberculosis diagnosis in children with HIV infection, as well as the safety and tolerability of first-line and many second-line antituberculous drugs in children,10 the sensitivity and specificity of this tool represent a reasonable risk/benefit ratio. Notably, the authors mention that their treatment-decision tool did not perform as well as expert clinicians, which is unsurprising given the nuanced clinical diagnosis of tuberculosis. Nonetheless, when used at the primary care level by front-line providers, this tool may facilitate the diagnosis and timely treatment of tuberculosis in children co-infected with HIV and tuberculosis and, in doing so, may save lives.

    Footnotes

      • Accepted June 11, 2019.
    • Address correspondence to Andrea T. Cruz, MD, MPH, Department of Pediatrics, Baylor College of Medicine, 6621 Fannin St, Suite A2210, Houston, TX 77030. E-mail: acruz{at}bcm.edu
    • Opinions expressed in these commentaries are those of the authors and not necessarily those of the American Academy of Pediatrics or its Committees.

    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: Dr Chiang is supported by the US National Institutes of Health (grant K01TW010829). Funded by the National Institutes of Health (NIH).

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    • COMPANION PAPER: A companion to this article can be found online at www.pediatrics.org/cgi/doi/10.1542/peds.2018-2065.

    References

    1. ↵
      1. Dodd PJ,
      2. Yuen CM,
      3. Sismanidis C,
      4. Seddon JA,
      5. Jenkins HE
      . The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–e906pmid:28807188
      OpenUrlPubMed
    2. ↵
      1. Jenkins HE,
      2. Yuen CM,
      3. Rodriguez CA, et al
      . Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–295pmid:27964822
      OpenUrlPubMed
    3. ↵
      1. DiNardo AR,
      2. Detjen A,
      3. Ustero P,
      4. Ngo K,
      5. Bacha J,
      6. Mandalakas AM
      . Culture is an imperfect and heterogeneous reference standard in pediatric tuberculosis. Tuberculosis (Edinb). 2016;101S:S105–S108pmid:27727131
      OpenUrlPubMed
    4. ↵
      1. Chiang SS,
      2. Cruz AT,
      3. Del Castillo H,
      4. Contreras C,
      5. Becerra MC,
      6. Lecca L
      . Evaluation of health-care providers’ knowledge of childhood tuberculosis in Lima, Peru. Paediatr Int Child Health. 2015;35(1):29–35pmid:25161060
      OpenUrlCrossRefPubMed
    5. ↵
      1. United Nations Children’s Fund
      . Global and regional trends. Available at: https://data.unicef.org/topic/hivaids/global-regional-trends/. Accessed May 29, 2019
    6. ↵
      1. Dodd PJ,
      2. Prendergast AJ,
      3. Beecroft C,
      4. Kampmann B,
      5. Seddon JA
      . The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis. Thorax. 2017;72(6):559–575pmid:28115682
      OpenUrlAbstract/FREE Full Text
    7. ↵
      1. Graham SM
      . The use of diagnostic systems for tuberculosis in children. Indian J Pediatr. 2011;78(3):334–339pmid:21165720
      OpenUrlCrossRefPubMed
    8. ↵
      1. Marcy O,
      2. Borand L,
      3. Ung V, et al; ANRS 12229 PAANTHER 01 Study Group
      . A treatment-decision score for HIV-infected children with suspected tuberculosis. Pediatrics. 2019;144(3):e20182065
      OpenUrlAbstract/FREE Full Text
    9. ↵
      1. Swingler GH,
      2. du Toit G,
      3. Andronikou S,
      4. van der Merwe L,
      5. Zar HJ
      . Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis. Arch Dis Child. 2005;90(11):1153–1156pmid:16243870
      OpenUrlAbstract/FREE Full Text
    10. ↵
      1. World Health Organization
      . Treatment of tuberculosis in children: rapid advice. Available at: https://www.who.int/tb/publications/tb-children-rapidadvice/en/. Accessed May 29, 2019
    • Copyright © 2019 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 144, Issue 3
    1 Sep 2019
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Minding (and Reducing) the Detection Gap: An Algorithm to Diagnose TB With HIV Infection
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    Minding (and Reducing) the Detection Gap: An Algorithm to Diagnose TB With HIV Infection
    Silvia S. Chiang, Andrea T. Cruz
    Pediatrics Sep 2019, 144 (3) e20191797; DOI: 10.1542/peds.2019-1797

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Minding (and Reducing) the Detection Gap: An Algorithm to Diagnose TB With HIV Infection
    Silvia S. Chiang, Andrea T. Cruz
    Pediatrics Sep 2019, 144 (3) e20191797; DOI: 10.1542/peds.2019-1797
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • Comments

    Related Articles

    • No related articles found.
    • PubMed
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    • Ensuring the Safety of Maternal Immunization
    • Evaluating Intersectionality of Policies and Populations
    • Safety of Breastfeeding by Mothers With COVID-19: New Evidence From Israel
    Show more Commentary

    Similar Articles

    Subjects

    • International Child Health
      • International Child Health
    • Infectious Disease
      • Infectious Disease
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics